G
Glocalink
Venture CapitalModerateGlocalink provides seed funding and comprehensive support for emerging science & technology entrepreneurs.
9
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Glocalink.
Investment Thesis & Strategy
Glocalink invests in seed-stage science and technology companies, providing both funding and support to help entrepreneurs grow their businesses.
Investment Activity
Deals per year over the last 11 years
1
20130
20140
20150
20161
20171
20180
20192
20202
20212
20221
2023Portfolio Companies
Selected investments from their portfolio of 9 companies
N
Nabla Bio
Biotech · Seed, 2023
I
InnoSkel
Biotech · Series A, 2022
O
Obsidio Therapeutics
Biotech · Seed, 2022
H
HAYA Therapeutics
Biotech · Series A, 2021
V
Volumetric
Biotech · Seed, 2021
A
Agomab Therapeutics
Biotech · Series A, 2020
T
T-knife Therapeutics
Biotech · Series B, 2020
T
Triumvira Immunologics
Biotech · Series A, 2018
C
Cellestia Biotech
Biotech · Series A, 2017
I
InSphero
Biotech · Series B, 2013
Frequently Asked Questions
Glocalink focuses on Series A, Series B, Series C+ stage investments.